Efficacy comparison of lamivudine combined with adefovir dipivoxil de novo and entecavir monotherapy in treatment of patients with hepatitis B virus-related decompensated cirrhosis

Chinese Pharmaceutical Journal

Volumn 47, Issue 18, 2012, Pages 1453-1456

  Jia, Hong Yu ^a   Ma, Kui Fen ^a   Lv, Guo Cai ^a   Zheng, Lin ^a   Yang, Yi Da ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Efficacy; Entecavir; HBV related decompensated cirrhosis; Lamivudine combined with adefovir dipivoxil de novo

Indexed keywords

ADEFOVIR DIPIVOXIL; CREATININE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DECOMPENSATED LIVER CIRRHOSIS; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; TREATMENT DURATION; VIRUS RESISTANCE;

EID: 84867677491     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. LU F M, ZHUANG H. Management of hepatitis B in China[J]. Chin Med J, 2009, 122(1): 3-4.
2. DE JONGH F E, JANSSEN H I, DE MAN R A, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver[J]. Gastroenterology, 1992, 103(5): 1630-1635.
3. LIAW Y F, SUNG J J, CHOW W C, et al. Cirrhosis Asian lamivudine multicentre study group. Lamivudine for patients with chronic hepatitis B and advanced liver disease[J]. N Engl J Med, 2004, 351(15): 1521-1531.
4. European Association For The Study of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50(2): 227-242.
5. LIAW Y F, LEUNG N, KAO J H, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update[J]. Hepatol Int, 2008, 2(3): 263-283.
6. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guildeline of prevention and treatment of chronic hepatitis B[J]. Chin J Hepatol, 2005, 13(12): 881-891.
7. CHANG T T, GISH R G, DE MAN R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B[J]. N Engl J Med, 2006, 354(10): 1001-1010.
8. SHIM J H, LEE H C, KIM K M, et al. Efficacy of entecavir in treatmentnave patients with hepatitis B virus-related decompensated eirrhosis[J]. J Hepatol, 2010, 52(2): 176-182.
9. PERRILLO R P, WRIGHT T, RAKELA J, et al. Lamivudine North American Transplant Group. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[J]. Hepatology, 2001, 33(2): 424-432.
10. LANGE C M, BOJUNGA J, HOFMANN W P, et al. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function[J]. Hepatology, 2009, 50(6): 2001-2006.